Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
May 05, 2017Aristoteles Giagounidis, MD: Optimal use of lenalidomide as therapy for MDSWebcast: European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes 201724 minPlay
May 05, 2017Jaroslav Cermak, MD, Ph: Experimental therapeutics in MDS – New opportunitiesWebcast: European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes 201720 minPlay
May 05, 2017Hans Michael Kvasnicka, MD, PhD: MF marrow morphology: Key takeaways from WHO 2016 diagnostic updateWebcast: European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes 201722 minPlay
May 05, 2017Claire Harrison, DM, FRCP, FRCPath: My approach to MF managementWebcast: European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes 201721 minPlay
May 05, 2017Srdan Verstovsek, MD, PhD: Clonal evolution of MPN to accelerated or blastic phase: Therapeutic insightsWebcast: European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes 201724 minPlay
May 05, 2017Alessandro M. Vannucchi, MD: Experimental therapeutics in MPN: Where is the field going?Webcast: European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes 201722 minPlay
April 21, 2017Paul G. Richardson, MD: Debate: Post-transplant maintenance for multiple myeloma - Lenalidomide aloneWebcast: Great Debates and Updates in Hematologic Malignancies 201716 minPlay
April 21, 2017Ruben Niesvizky, MD: Debate: Salvage therapy for multiple myeloma - Should be the same for everyoneWebcast: Great Debates and Updates in Hematologic Malignancies 201717 minPlay
April 21, 2017Richard R. Furman, MD: Debate: Is it appropriate to treat patients with CLL earlier in the era of novel agents? - NoWebcast: Great Debates and Updates in Hematologic Malignancies 201713 minPlay
April 21, 2017Jae Park, MD: New approaches to Hairy Cell LeukemiaWebcast: Great Debates and Updates in Hematologic Malignancies 201722 minPlay